TG Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Okay. Good morning. Thanks for joining us for the 40th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, Senior Biotech Analyst with the firm. Our next presenting company is TG Therapeutics, and it's my pleasure to welcome CEO, Mike Weiss, to talk to us a little about the company.
There is a Q&A session after the presentation. (Operator Instructions) With that, Mike, thanks for joining us.
Thanks, Eric. Really appreciate it. Thanks for having me. I guess you said the 40th Annual. I guess I'm not as old as I thought. I think I'm on my 20-something JPMorgan conference. But really pleased to be here. Hopefully, next year, we'll get to do this live. Finally, I made it off of Wednesday, Thursday and unfortunately, it's virtual, but we'll get there. So thanks again for having us.
Next slide, please. So just on the Slide 2. I will be making some forward-looking statements. So for
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |